Sudden cardiac arrest may occur in various conditions when someone, while active (playing basketball or walking with friends) ...

The FDA has approved intranasal etripamil (Cardamyst; Milestone Pharmaceuticals) for the acute treatment of paroxysmal supraventricular tachycardia (PSVT), making it the first self-administered, ...

In hospitalized adults with coronavirus disease 2019 (COVID-19) and no structural heart disease, cardiac arrhythmias were common and were strongly associated with myocardial injury and poor blood ...

HeartBeam’s ECG software duplicates the 12-lead ECG approach undertaken in healthcare settings with electrodes to evaluate ...

HeartBeam's 1st synthesized 12-lead ECG cleared by FDA, enabling cable-free at-home arrhythmia assessment with launch set for 2026.

Experts discuss how arrhythmia evaluation is tailored based on symptom frequency, severity, and patient risk, using a stepwise approach from short-term to extended monitoring to guide timely and ...

There is an indisputable trend toward minimally invasive, outpatient procedures in healthcare. Outpatient procedures help to alleviate burdens on the healthcare system, save patients time, money, and ...

Myocardial infarction remains one of the leading causes of mortality, which is usually complicated by the occurrence of ischemic ventricular arrhythmias, which in turn increase the risk of sudden ...